详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Yuan, Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] * ; Deng, Yanhong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Jin, Yongdong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]

; Pan, Yueyin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Wang, Cunji[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Wang, Zhiwu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Zhang, Zhiye[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Meng, Xiangjiao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Hu, Yi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Zhao, Mingfang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Wang, Huijuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Yang, Nong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Wu, Dongde[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Dong, Xiaorong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Huang, Dingzhi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Sun, Meili[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Liu, Lian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Hua, Dong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Guo, Zengqing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Ding, Ke-Feng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ;

机构： [1]Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China [2]Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China [3]Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China [4]Anhui Prov Hosp, Dept Tumor Chemotherapy, Hefei, Peoples R China [5]Hunan Tradit Chinese Med Co, Dept Oncol, Affiliated Hosp 1, Zhuzhou, Peoples R China [6]Tangshan Peoples Hosp, Dept Radiochem 2, Tangshan, Peoples R China [7]Henan Univ Sci & Technol, Dept Med Oncol, Affiliated Hosp 1, Luoyang, Peoples R China [8]Shandong Prov Canc Hosp, Thorac Radiat Oncol Ward IV, Jinan, Peoples R China [9]Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Med Ctr 1, Beijing, Peoples R China [10]China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China [11]Henan Canc Hosp, Resp Dept, Zhengzhou, Peoples R China [12]Hunan Canc Hosp, Lung & Gastrointestinal Oncol Dept, Changsha, Peoples R China [13]Hubei Canc Hosp, Hepatopancreatobiliary Surg Dept, Wuhan, Peoples R China [14]Huazhong Univ Sci & Technol, Dept Thorac Oncol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [15]Tianjin Med Univ Canc Inst & Hosp, Dept Pulm Oncol, Tianjin, Peoples R China [16]Shandong First Med Univ, Dept Med Oncol, Cent Hosp, Jinan, Peoples R China [17]Shandong Univ, Dept Med Oncol, Qilu Hosp, Jinan, Peoples R China [18]Wuxi Peoples Hosp, Dept Oncol, Wuxi, Jiangsu, Peoples R China [19]Fujian Canc Hosp, Fuzhou, Peoples R China [20]Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg & Oncol, Key Lab Canc Prevent & Intervent,Minist Educ,Sch, Hangzhou, Zhejiang, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China [2]Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China [3]Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China [4]Anhui Prov Hosp, Dept Tumor Chemotherapy, Hefei, Peoples R China [5]Hunan Tradit Chinese Med Co, Dept Oncol, Affiliated Hosp 1, Zhuzhou, Peoples R China [6]Tangshan Peoples Hosp, Dept Radiochem 2, Tangshan, Peoples R China [7]Henan Univ Sci & Technol, Dept Med Oncol, Affiliated Hosp 1, Luoyang, Peoples R China [8]Shandong Prov Canc Hosp, Thorac Radiat Oncol Ward IV, Jinan, Peoples R China [9]Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Med Ctr 1, Beijing, Peoples R China [10]China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China [11]Henan Canc Hosp, Resp Dept, Zhengzhou, Peoples R China [12]Hunan Canc Hosp, Lung & Gastrointestinal Oncol Dept, Changsha, Peoples R China [13]Hubei Canc Hosp, Hepatopancreatobiliary Surg Dept, Wuhan, Peoples R China [14]Huazhong Univ Sci & Technol, Dept Thorac Oncol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [15]Tianjin Med Univ Canc Inst & Hosp, Dept Pulm Oncol, Tianjin, Peoples R China [16]Shandong First Med Univ, Dept Med Oncol, Cent Hosp, Jinan, Peoples R China [17]Shandong Univ, Dept Med Oncol, Qilu Hosp, Jinan, Peoples R China [18]Wuxi Peoples Hosp, Dept Oncol, Wuxi, Jiangsu, Peoples R China [19]Fujian Canc Hosp, Fuzhou, Peoples R China [20]Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg & Oncol, Key Lab Canc Prevent & Intervent,Minist Educ,Sch, Hangzhou, Zhejiang, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRAS(G12C) mutation: Preliminary results from a pooled analysis of two phase I studies

文献详情